MSH2 and cancer: It aims to detect lack of MMR protein(s) as MLH1, MSH2, MSH6, and/or PMS2 [7, 8], which can be misleading partly because the diagnosis depends on ‘loss’ of staining in cancer cells among co-existing stromal cells that show normal levels of expression.